Distinguishing between exploratory and confirmatory preclinical research will improve translation.
Preclinical researchers confront two overarching agendas related to drug development: selecting interventions amid a vast field of candidates, and producing rigorous evidence of clinical promise for a small number of interventions. We suggest that each challenge is best met by two different, complem...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/835d26b2650a48708202d848d2b3fd7d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:835d26b2650a48708202d848d2b3fd7d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:835d26b2650a48708202d848d2b3fd7d2021-11-11T05:37:10ZDistinguishing between exploratory and confirmatory preclinical research will improve translation.1544-91731545-788510.1371/journal.pbio.1001863https://doaj.org/article/835d26b2650a48708202d848d2b3fd7d2014-05-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24844265/?tool=EBIhttps://doaj.org/toc/1544-9173https://doaj.org/toc/1545-7885Preclinical researchers confront two overarching agendas related to drug development: selecting interventions amid a vast field of candidates, and producing rigorous evidence of clinical promise for a small number of interventions. We suggest that each challenge is best met by two different, complementary modes of investigation. In the first (exploratory investigation), researchers should aim at generating robust pathophysiological theories of disease. In the second (confirmatory investigation), researchers should aim at demonstrating strong and reproducible treatment effects in relevant animal models. Each mode entails different study designs, confronts different validity threats, and supports different kinds of inferences. Research policies should seek to disentangle the two modes and leverage their complementarity. In particular, policies should discourage the common use of exploratory studies to support confirmatory inferences, promote a greater volume of confirmatory investigation, and customize design and reporting guidelines for each mode.Jonathan KimmelmanJeffrey S MogilUlrich DirnaglPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Biology, Vol 12, Iss 5, p e1001863 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Biology (General) QH301-705.5 |
spellingShingle |
Biology (General) QH301-705.5 Jonathan Kimmelman Jeffrey S Mogil Ulrich Dirnagl Distinguishing between exploratory and confirmatory preclinical research will improve translation. |
description |
Preclinical researchers confront two overarching agendas related to drug development: selecting interventions amid a vast field of candidates, and producing rigorous evidence of clinical promise for a small number of interventions. We suggest that each challenge is best met by two different, complementary modes of investigation. In the first (exploratory investigation), researchers should aim at generating robust pathophysiological theories of disease. In the second (confirmatory investigation), researchers should aim at demonstrating strong and reproducible treatment effects in relevant animal models. Each mode entails different study designs, confronts different validity threats, and supports different kinds of inferences. Research policies should seek to disentangle the two modes and leverage their complementarity. In particular, policies should discourage the common use of exploratory studies to support confirmatory inferences, promote a greater volume of confirmatory investigation, and customize design and reporting guidelines for each mode. |
format |
article |
author |
Jonathan Kimmelman Jeffrey S Mogil Ulrich Dirnagl |
author_facet |
Jonathan Kimmelman Jeffrey S Mogil Ulrich Dirnagl |
author_sort |
Jonathan Kimmelman |
title |
Distinguishing between exploratory and confirmatory preclinical research will improve translation. |
title_short |
Distinguishing between exploratory and confirmatory preclinical research will improve translation. |
title_full |
Distinguishing between exploratory and confirmatory preclinical research will improve translation. |
title_fullStr |
Distinguishing between exploratory and confirmatory preclinical research will improve translation. |
title_full_unstemmed |
Distinguishing between exploratory and confirmatory preclinical research will improve translation. |
title_sort |
distinguishing between exploratory and confirmatory preclinical research will improve translation. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/835d26b2650a48708202d848d2b3fd7d |
work_keys_str_mv |
AT jonathankimmelman distinguishingbetweenexploratoryandconfirmatorypreclinicalresearchwillimprovetranslation AT jeffreysmogil distinguishingbetweenexploratoryandconfirmatorypreclinicalresearchwillimprovetranslation AT ulrichdirnagl distinguishingbetweenexploratoryandconfirmatorypreclinicalresearchwillimprovetranslation |
_version_ |
1718439509429846016 |